Angus Dalgleish

Angus George Dalgleish (born 1950 in London)cite web | url = http://www.sgul.ac.uk/index.cfm?733CD1EE-F306-7ABF-9D50-77AF3EA71A4A| title = Biography | publisher = St. George's University of London | accessdate = 2008-10-10] Bsc (Hons), MD FRACPath FRACP FRCP FMedSci cite web | url = http://www.londononcology.com/about_us/Professor_Angus_Dalgleish.aspx | publisher = London Oncology Clinic | title = Biography | accessdate = 2008-10-10] is a specialist in the fields of cancer immunology and HIV research.

Education

Initially educated at the Harrow County School for Boys, Dalgleish received a Bachelor of Medicine and Surgery degree from University College London with an intercalated Bachelor of Science degree in Anatomy.

After various positions in the United Kingdom, Dalgleish joined the flying doctor service in Mount Isa, Queensland, then progressed through positions at various hospitals in Brisbane, Australia before moving to the Ludwig Institute for Cancer Research in Sydney.

Career

After completion of his training, Dalgleish returned to work in the UK in 1984 at the Institute of Cancer Research, where he helped identify CD4 as the major cellular receptor for HIV. [cite book | url = http://books.google.co.uk/books?id=9k3HmC2YfMcC&pg=PA283&lpg=PA283&dq=CD4+%22angus+dalgleish%22&source=web&ots=o7t2Q_ftdU&sig=vdaeFMyLC2WvODe1I5QQFyKLJq8&hl=en&sa=X&oi=book_result&resnum=1&ct=result | title = Molecular and Cell Biology of Sexually Transmitted Diseases | year=1992|first1=David | last1=Wilks| first2=Angus | last2=Dalgleish| publisher=Springer | isbn=9780412365102|page=283] [cite web | url = http://www.hasumi-foundation.org/bio011.html | title = Biography | publisher = Hasumi International Research Foundation |accessdate=2008-10-10] [cite book | url = http://books.google.co.uk/books?id=mU_iQEIjs8IC&pg=PA52&lpg=PA52&dq=CD4+%22angus+dalgleish%22&source=web&ots=rwMGHq24Mu&sig=dUl6bwlaFa_9yC6cA4WRZv8EP7I&hl=en&sa=X&oi=book_result&resnum=5&ct=result | title = AIDS in the UK | last = Berridge | first = Virginia | pages=52 |isbn=9780198204732 | publisher = Oxford University Press] In 1986, he was appointed to a consulting position at Northwick Park Hospital, in 1991 he was made Foundation Professor of Oncology at St George's, University of London., and in 1994 he was appointed Visiting Professor at the Institute of Cancer Research.

In 1997, he founded Onyvax Ltd., a privately funded biotechnology company developing cancer vaccines, where he holds a position as Research Director. [cite web | url = http://www.onyvax.com/data/Onyvax%20Corporate%20Fact%20Sheet.pdf | publisher = Onyvax Ltd | title = Corporate Fact Sheet | format = PDF | accessdate = 2008-10-10]

Partial bibliography

*citation| url = http://www.biomedcentral.com/render/render.asp?arx_id=cd-581663&type=pdf&access=denied | title = Novel immunotheraputic approaches to prostate cancer | journal=Current Opinion in Molecular Theraputics | year=2005 | issue=7 | pages=30-34 | last = Dalgleish | first = Angus | last2 = Whelan | first2 = M
*citation | url = http://www.nature.com/nm/journal/v1/n9/abs/nm0995-881.html | title = HIV and CD26 | journal = Nature Medicine | year = 1995 | doi=10.1038/nm0995-881
*cite journal | title = Immunotherapeutic potential of whole tumour cells | accessdate = 2008-10-10 |url = http://www.springerlink.com/content/a88nu01yyxxjvyrv/ | coauthors=Stephen Ward, David Casey, Marie-Christine Labarthe, Michael Whelan, Angus Dalgleish, Hardev Pandha, Stephen Todryk | doi=10.1007/s00262-002-0286-2 |journal = Cancer Immunology, Immunotherapy | date=September 2002 | volume = 51 | issue = 7 | pages = 351-357
*citation | url = http://www.nice.org.uk/nicemedia/pdf/CSG_Skin_EvidenceReview.pdf | format = PDF | title = Improving Outcomes for People with Skin Tumours including Melanoma | publisher = National Institute for Health and Clinical Excellence | date = February 2006 |pages=525-535

References